Stay updated on Cabozantinib in Advanced Solid Malignancies Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Solid Malignancies Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Solid Malignancies Clinical Trial page
- Check5 days agoChange DetectedA new revision label 'Revision: v3.5.2' was added and the old 'Revision: v3.5.0' label was removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior lapse-in-funding notice (Revision: v3.4.1). These appear to be maintenance/status updates rather than changes to the study details.SummaryDifference0.5%

- Check76 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH Clinical Center operating status was added and the revision tag updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check83 days agoChange DetectedMinor UI/text updates include adding a 'Show glossary' toggle, capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the revision label updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib in Advanced Solid Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Solid Malignancies Clinical Trial page.